KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001691102-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | May 27, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
8,216
Total Value
$52,645.15
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF DEVELOPMENT OFFICER | Common Stock | โ | May 22, 2026 | Exercise/Conversion | 3,125 | โ | โ | 231,884 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Common Stock | โ | May 26, 2026 | Sale | 1,966 | $26.78 | $52,645.15 | 229,918 | Direct | โ | View Details | |
CHIEF DEVELOPMENT OFFICER | Restricted Stock Unit | Derivative | May 22, 2026 | Exercise/Conversion | 3,125 | $0.00 | $0.00 | 25,000 | Direct | โ | View Details |